Primary Care/Hospitalist
RSSArticles
-
Contraceptive Access Issues Require a Different Kind of Understanding
Contraceptive access initiatives often have focused on long-acting contraceptive methods, such as intrauterine devices and implants. These initiatives analyzed provider-level and financial access barriers to contraceptive methods. But this way of thinking has changed. Family planning experts now are examining access issues within a person-centered contraceptive care framework. This framework conceptualizes access according to what individual women want in contraceptives — not just around what they can afford and what is available.
-
Rheumatology Association Issues Its First Reproductive Health Guidelines
The 2020 Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases is the first set of evidence-based recommendations regarding contraception and other reproductive health issues from the American College of Rheumatology.
-
Title X Final Rule Is Troubling for Providers
The recent Title X changes enacted by the Trump administration are creating major ethical dilemmas and operational challenges for family planning and reproductive health clinics nationwide.
-
Title X Problems Worsen with Recent Court Decision
The recent Title X changes have proven devastating to women depending on family planning centers for their reproductive healthcare needs. The 9th U.S. Circuit Court of Appeals ruling upheld the Trump administration’s gag rule that prohibits Title X providers from referring patients for abortion care or even answering questions about abortion.
-
How Providers Can Weather the Pandemic
As pandemic messaging moves from containment to mitigation to recovery, national experts are giving healthcare providers tips on how to weather the storm.
-
COVID-19 Shuts Down Nation; Family Planning Need Not Stop
The COVID-19 pandemic has affected every aspect of American life, including nonemergency doctor visits. But from a family reproductive health point of view, the consequences of weeks of social distancing and quarantines can present new challenges.
-
This ECG Was in Your ‘Pile to be Read’
Imagine the ECG in the figure was one of many tracings you received to read from a group of patients seen by other providers in your clinic. Unfortunately, no clinical information about this patient was available. How would one interpret this tracing? Considering no clinical information regarding what happened to the patient was available, what is the next step?
-
Rimegepant Orally Disintegrating Tablet (Nurtec ODT)
Rimegepant should be prescribed to treat acute migraine with or without aura in adults.
-
Diagnostic Criteria for Small Fiber Neuropathy
Multiple clinical tools have emerged to assess small fiber nerve dysfunction, but validated diagnostic criteria are needed to optimize diagnostic sensitivity, support clinical management, and facilitate patient selection for clinical trials.
-
Home Oral Factor Xa Inhibitor Treatment for Pulmonary Embolism
Low-risk pulmonary embolus patients discharged in < 48 hours on rivaroxaban recorded a nominal three-month rate of recurrent emboli or major bleeding, suggesting such patients do not need to be hospitalized for treatment of pulmonary emboli.